Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Amyotrophic lateral sclerosis | 2 | 4 | |
Myalgic encephalomyelitis/chronic fatigue syndrome | 1 | 3 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 7 |
Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Amyotrophic lateral sclerosis | 2 | 4 | |
Myalgic encephalomyelitis/chronic fatigue syndrome | 1 | 3 |
Severity | Evaluations | Percentage |
---|---|---|
Severe | 0 | |
Moderate | 0 | |
Mild | 0 | |
None | 7 |